SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group
0 references·7 citing·22 second hop
Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group (1996)Lifetime benefits and costs of intensive …Economic Evaluation of a Pharmaceutical Care Program for Elderly Diabetic and Hypertensive Patients in Primary Health Care: A 36-Month Randomized Controlled Clinical Trial (2015)Economic Evaluation of a Phar…The Cost‐Effectiveness of Improving Diabetes Care in U.S. Federally Qualified Community Health Centers (2007)The Cost‐Effectiveness of Imp…Productivity and Medical Costs of Diabetes in a Large Employer Population (2002)Productivity and Medical Cost…Productivity Losses Associated With Diabetes in the U.S. (2001)Productivity Losses Associate…Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51) (2001)Cost-effectiveness analysis o…Excess Costs of Diabetes in the Aboriginal Population of Manitoba, Canada (2000)Excess Costs of Diabetes in t…Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study (2000)Cost-effectiveness of intensi…The Economic Costs of Non—Insulin-Dependent Diabetes Mellitus (1989)Health care expenditures for people with diabetes mellitus, 1992. (1994)Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Methods for the economic evaluation of health care programmes (1987)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Cost-Effectiveness in Health and Medicine (1996)Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63) (2002)Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)The Cost-Effectiveness of Personalized Genetic Medicine (2011)A Theory of the Allocation of Time (1965)Leisure, Home Production and Work--The Theory of The Allocation of Time Revisited (1976)Limited-dependent and qualitative variables in econometrics (1983)Workplace discrimination and diabetes: The EEOC Americans with Disabilities Act research project (2005)The impact of diabetes on labour market participation: a systematic review of results and methods (2019)Estimating Costs in Cost Effectiveness Analysis (1996)The Case for “Outsourcing” Diabetes Care (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction (1993)Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team (1995)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2001Productivity Losses Associated With Diabetes in the U.S.118 cited
  • 2015Economic Evaluation of a Pharmaceutical Care Program for Elderly Diabetic and Hypertensive Patients in Primary Health Care: A 36-Month Randomized Controlled Clinical Trial110 cited
  • 2002Productivity and Medical Costs of Diabetes in a Large Employer Population105 cited
  • 2007The Cost‐Effectiveness of Improving Diabetes Care in U.S. Federally Qualified Community Health Centers104 cited
  • 2000Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study100 cited
  • 2001Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51)99 cited
  • 2000Excess Costs of Diabetes in the Aboriginal Population of Manitoba, Canada30 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work